Protalix BioTherapeutics
PLX
#8866
Rank
A$0.21 B
Marketcap
A$2.69
Share price
2.26%
Change (1 day)
-11.33%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): A$11.65 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$61.84 Million. In 2024 the company made an earning of A$7.75 Million a decrease over its 2023 earnings that were of A$17.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$11.65 M50.25%
2024 A$7.75 M-55.62%
2023 A$17.48 M-199.05%
2022 -A$17.66 Million-40.38%
2021 -A$29.61 Million-732.31%
2020 A$4.68 M-130.53%
2019 -A$15.34 Million189.85%
2018 -A$5.3 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$27.54 Million-32.37%
2015 -A$40.72 Million10.11%
2014 -A$36.98 Million-7.59%
2013 -A$40.01 Million
2011 -A$46.34 Million-19.39%
2010 -A$57.48 Million20.87%
2009 -A$47.56 Million32.26%
2008 -A$35.96 Million-5.46%
2007 -A$38.03 Million
2004 -A$0.25 Million12.35%
2003 -A$0.22 Million-11.1%
2002 -A$0.25 Million-57.03%
2001 -A$0.58 Million1.03%
2000 -A$0.57 Million-53.22%
1999 -A$1.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
A$7.41 M-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.86 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.62 B 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.63 B 23,656.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel